Accelerating drug development by early unwanted immunogenicity testing

25 September 2019

In this video, Miltenyi Biotec discusses how immunogenicity prediction can save precious time when applied in the early phases of drug development. This webinar discusses the best practices in assessing unwanted immune responses and highlights how the MACSQuant® X Flow Cytometer is designed to provide speed and reliability in high-throughput screening.